Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial Of C2B8 Monoclonal Antibody Following High Dose Therapy And Autografting In B-Cell Non-Hodgkin's Lymphoma

NCT00225212 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00225212
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00225212 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial Of C2B8 Monoclonal Antibody Following High Dose Therapy And Autografting In B-Cell Non-Hodgkin's Lymphoma
Lead sponsor
Stanford University
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1997
Completion date
March 31, 2003
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large cell lymphoma, lymphoma, mantle cell lymphoma, non-hodgkin's lymphoma, other subtypes of b-cell lymphoma, transformed lymphoma